Patents by Inventor Cory Batenchuk

Cory Batenchuk has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12175738
    Abstract: Methods and systems are disclosed for image process biological samples to infer biomarker values. An image of a biological sample can be accessed. The image can be segmented into a set of patches. Edge detection performed on each patch can be used to identify one or more biological features represented by the patch. An indication of the one or more features of each patch may be used to generate one or more image level metrics. A value of a biomarker may be inferred using the one or more image level metrics. The value of the biomarker can then be output.
    Type: Grant
    Filed: March 28, 2023
    Date of Patent: December 24, 2024
    Assignee: VERILY LIFE SCIENCES LLC
    Inventors: Cory Batenchuk, Huang-Wei Chang, Peter Cimermancic, Kimary Kulig, Graziella Solinas
  • Publication number: 20240060983
    Abstract: Provided herein are compositions and methods for assaying target proteins on extracellular vesicles in plasma. In some methods, the responsiveness of a subject to immunotherapy is determined.
    Type: Application
    Filed: December 21, 2021
    Publication date: February 22, 2024
    Applicant: Verily Life Sciences LLC
    Inventors: Cory Batenchuk, Jia Lin, Kimary Kulig, Adrian Lobito, Daniel Liu, Wilman Luk, James Sullivan
  • Publication number: 20230245439
    Abstract: Methods and systems are disclosed for image process biological samples to infer biomarker values. An image of a biological sample can be accessed. The image can be segmented into a set of patches. Edge detection performed on each patch can be used to identify one or more biological features represented by the patch. An indication of the one or more features of each patch may be used to generate one or more image level metrics. A value of a biomarker may be inferred using the one or more image level metrics. The value of the biomarker can then be output.
    Type: Application
    Filed: March 28, 2023
    Publication date: August 3, 2023
    Applicant: Verily Life Sciences LLC
    Inventors: Cory Batenchuk, Huang-Wei Chang, Peter Cimermancic, Kimary Kulig, Graziella Solinas
  • Patent number: 11629384
    Abstract: Methods and systems are disclosed for image process biological samples to infer biomarker values. An image of a biological sample can be accessed. The image can be segmented into a set of patches. Edge detection performed on each patch can be used to identify one or more biological features represented by the patch. An indication of the one or more features of each patch may be used to generate one or more image level metrics. A value of a biomarker may be inferred using the one or more image level metrics. The value of the biomarker can then be output.
    Type: Grant
    Filed: October 14, 2019
    Date of Patent: April 18, 2023
    Assignee: VERILY LIFE SCIENCES LLC
    Inventors: Cory Batenchuk, Huang-Wei Chang, Peter Cimermancic, Kimary Kulig, Graziella Solinas
  • Publication number: 20210346441
    Abstract: There is described herein a non-replicating Rhabdovirus-derived particle that lacks the ability to spread between cells while having tropism against immortalized cells. The non-replicating Rhabdovirus-derived particle may have cytolytic tropism against immortalized cells. There is also described a non-replicating Rhabdovirus-derived particle that lacks the ability to spread between cells but has innate and/or adaptive immune-stimulating properties.
    Type: Application
    Filed: July 21, 2021
    Publication date: November 11, 2021
    Inventors: David Conrad, Cory Batenchuk, Fabrice Leboeuf, John Cameron Bell
  • Patent number: 11110138
    Abstract: There is described herein a non-replicating Rhabdovirus-derived particle that lacks the ability to spread between cells while having tropism against immortalized cells. The non-replicating Rhabdovirus-derived particle may have cytolytic tropism against immortalized cells. There is also described a non-replicating Rhabdovirus-derived particle that lacks the ability to spread between cells but has innate and/or adaptive immune-stimulating properties.
    Type: Grant
    Filed: December 20, 2013
    Date of Patent: September 7, 2021
    Assignee: CELVERUM INC.
    Inventors: David Conrad, Cory Batenchuk, Fabrice Leboeuf, John Cameron Bell
  • Publication number: 20200123618
    Abstract: Methods and systems are disclosed for image process biological samples to infer biomarker values. An image of a biological sample can be accessed. The image can be segmented into a set of patches. Edge detection performed on each patch can be used to identify one or more biological features represented by the patch. An indication of the one or more features of each patch may be used to generate one or more image level metrics. A value of a biomarker may be inferred using the one or more image level metrics. The value of the biomarker can then be output.
    Type: Application
    Filed: October 14, 2019
    Publication date: April 23, 2020
    Applicant: Verily Life Sciences LLC
    Inventors: Cory Batenchuk, Huang-Wei Chang, Peter Cimermancic, Kimary Kulig, Graziella Solinas
  • Publication number: 20150320810
    Abstract: There is described herein a non-replicating Rhabdovirus-derived particle that lacks the ability to spread between cells while having tropism against immortalized cells. The non-replicating Rhabdovirus-derived particle may have cytolytic tropism against immortalized cells. There is also described a non-replicating Rhabdovirus-derived particle that lacks the ability to spread between cells but has innate and/or adaptive immune-stimulating properties.
    Type: Application
    Filed: December 20, 2013
    Publication date: November 12, 2015
    Inventors: David Conrad, Cory Batenchuk, Fabrice Leboeuf, John Cameron Bell